Szilard Voros, MD, discusses what he found the most interesting at the 2013 ADA and singles out the new SGLT2 inhibitor class of drugs as especially exciting. However, he cautions that they are very new and only time will tell regarding any safety aspects. He is intrigued by the concept …
Read More »Diabetes In Control
Szilard Voros, MD, Q14: Improved patient outcomes with DPMP test results
Szilard Voros, MD, talks about one of the most surprising aspects of the DPMP testing. Several hundred patients participated initially with their providers. The baseline panel results were given to their doctors who used the results to work with their patients. After the second test, results indicated that around a …
Read More »Editor’s Note, DCMS #153: How Red Food Dye in a Saline Solution Can Save Lives
Years ago, when a patient was referred to the pharmacy for instructions on how to start insulin, we would add red food coloring to the saline making it easier to see the exact amount of liquid in the test syringe. Over time, I have thought about this idea and why …
Read More »Letter from the Editor #693:
Over the past month, I’ve done 20 hours of CE including a full day becoming certified at immunizations. In our area, every pharmacy, doctor’s office and walk-in clinic offers flu shots, and as we move into the fall, the volume of flu shots given will grow exponentially. Even with the ease …
Read More »Urine Testing Can Screen for Cognitive Decline
Urine Testing Can Screen for Cognitive Decline See this week’s Item #2.
Read More »Top 10 Apps Doctors Recommend to Their Diabetic Patients
Top 10 Apps Doctors Recommend to Their Diabetic Patients Apps for managing diabetes and calculating the risk of cardiovascular disease are among the top 10 apps doctors recommend to their patients, according to researchers at Medical Economics.Top 10 Apps(pdf)
Read More »Kazano
Kazano Active ingredient(s): Alogliptin/metformin. Indication(s): Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM) when treatment with both alogliptin and metformin is appropriate.
Read More »Getting Extra Sleep on Weekends May Reduce Diabetes Risk
Peter Liu of the Los Angeles Biomedical Research Institute and colleagues at the University of Sydney checked insulin sensitivity in 19 non-diabetic men who slept about 6 hours a night during the workweek, but 10 hours on weekend nights. "By extending sleep to 10 hours a night versus 6 hours …
Read More »Tour de France Cyclists Live Longer
The average French competitor in the Tour de France lives about 6 years longer than their non-competitive French age-matched countrymen, Xavier Jouven, MD, a cardiologist at Hopital Europeen Georges-Pompidou, Paris, said at the European Society of Cardiology meeting. "We found a substantially and significantly lower mortality in French participants in …
Read More »113 Million Obese and 81 Million Overweight Cases in the US by 2022
The U.S. will continue to lead the trend of growing waistlines across the developed world, a new study predicted. Altogether, eight leading developed countries and Brazil will see an increase in obesity cases from about 167 million last year to 213 million by 2022. Brazil will be second to the …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.